Jardiance, 25mg Tablets, Medication for type 2 diabetes management, 30 tablets

Jardiance 25mg tablets are a medication specifically designed for the management of type 2 diabetes. The key active ingredient in Jardiance is empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Empagliflozin works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and lowering blood sugar levels. This mechanism helps to improve glycemic control in patients with type 2 diabetes. Jardiance not only helps in managing blood sugar levels but also offers additional benefits such as reducing the risk of cardiovascular events in patients with established cardiovascular disease. The tablets have a smooth texture and are easy to swallow, making them convenient for daily use.